Element contents
Series: Elements in Contentious Politics
The Contentious Politics of Global Health Movements
Contesting Patents in Pndemic Times
Published online by Cambridge University Press: 19 November 2025
Summary
While much research has addressed the regressive anti-vax protests, this Element focuses on campaigns by progressive social movements to promote the development of vaccines for Covid-19 and ensure their equal access on a global level. Over the course of the pandemic, health and care have become central claims, mobilising health workers and patients as well as citizens in general. Together with various local and national social movement organizations which converged on health rights, through the use of care and cure as bridging frames, transnational campaigns addressing patents on vaccines also unfolded. This Element analyses these transnational campaigns, with particular attention to their organisational models, repertoires of action and collective framing. It assesses their outcomes by considering the complex sets of opportunities and constraints that the Covid-19 pandemic presented for progressive social movements that fight for access to medicines and cures at a global level.
Information
- Type
- Element
- Information
- Series: Elements in Contentious PoliticsOnline ISBN: 9781009658591Publisher: Cambridge University PressPrint publication: 18 December 2025
References
Abbott, F. M. (2011). The Doha declaration on the TRIPS agreement and public health and the contradictory trend in bilateral and regional free trade agreements (SSRN Scholarly Paper 1977300). https://papers.ssrn.com/abstract=1977300.Google Scholar
Amnesty International. (2020, November). Briefing for WTO member states on the TRIPS waiver proposal for the prevention, containment and treatment of COVID-19. Amnesty International. www.amnesty.org/en/documents/ior40/3365/2020/en/.Google Scholar
Azedi, A., & Schofer, E. (2023). Assessing the anti-globalization movement: Protest against the WTO, IMF, and World Bank in cross-national perspective. The Sociological Quarterly, 64(3), 445–470. https://doi.org/10.1080/00380253.2023.2167672.CrossRefGoogle Scholar
Baker, B. K. (2018). A sliver of hope: Analyzing voluntary licenses to accelerate affordable access to medicines (SSRN Scholarly Paper 3123108). https://papers.ssrn.com/abstract=3123108.Google Scholar
Baker, B. K. (2020). Access to medicines activism: Collaboration, conflicts, and complementarities (SSRN Scholarly Paper 3538270). https://papers.ssrn.com/abstract=3538270.Google Scholar
Banaszak-Holl, J., Levitsky, S., & Zald, M. N. (2010). Social Movements and the Transformation of American Health Care. Oxford University Press.CrossRefGoogle Scholar
Barone, A. (2024). Repertoires of action and collective memory: The re-emergence of feminist self-managed health centers in Italy. Social Movement Studies. www.academia.edu/122056651/Repertoires_of_action_and_collective_memory_the_re_emergence_of_feminist_self_managed_health_centers_in_Italy.Google Scholar
Biehl, J. G. (2007). Will to Live: AIDS Therapies and the Politics of Survival. Princeton University Press.CrossRefGoogle Scholar
Birch, K., & Muniesa, F. (Eds.). (2020). Assetization: Turning Things into Assets in Technoscientific Capitalism. The MIT Press. https://doi.org/10.7551/mitpress/12075.001.0001.CrossRefGoogle Scholar
Boin, A., & Rhinard, M. (2023). Crisis management performance and the European Union: The case of COVID-19. Journal of European Public Policy, 30(4), 655–675. https://doi.org/10.1080/13501763.2022.2141304.CrossRefGoogle Scholar
Boli, J., & Thomas, G. M. (1999). Constructing World Culture: International Nongovernmental Organizations Since 1875. Stanford University Press.CrossRefGoogle Scholar
Bosi, L., & Zamponi, L. (2015). Direct social actions and economic crises: The relationship between forms of action and socio-economic context in Italy. Partecipazione E Conflitto, 8(2), Article 2.Google Scholar
Bourgeron, T., & Geiger, S. (2022). (De-)assetizing pharmaceutical patents: Patent contestations behind a blockbuster drug. Economy and Society, 51(1), 23–45. https://doi.org/10.1080/03085147.2022.1987752.CrossRefGoogle Scholar
Bracke, M. A. (2017). Feminism, the state, and the centrality of reproduction: Abortion struggles in 1970s Italy. Social History, 42(4), 524–546. https://doi.org/10.1080/03071022.2017.1368234.CrossRefGoogle Scholar
Brooks, E., de Ruijter, A., Greer, S. L., & Rozenblum, S. (2023). EU health policy in the aftermath of COVID-19: Neofunctionalism and crisis-driven integration. Journal of European Public Policy, 30(4), 721–739. https://doi.org/10.1080/13501763.2022.2141301.CrossRefGoogle Scholar
Brown, P. (2007). Toxic Exposures: Contested Illnesses and the Environmental Health Movement. Columbia University Press.CrossRefGoogle Scholar
Brown, P., & Zavestoski, S. (2004). Social movements in health: An introduction. Sociology of Health and Illness, 26(6), 679–694. https://doi.org/10.1111/j.0141-9889.2004.00413.x.CrossRefGoogle ScholarPubMed
Brown, P., Morello-Frosch, R., Zavestoski, S., & the Contested Illnesses Research Group (Eds.). (2012). Front matter. In Contested Illnesses (1st ed.). University of California Press; JSTOR. http://www.jstor.org/stable/10.1525/j.ctt7zw1q9.1.Google Scholar
Buckland-Merrett, G. L., Kilkenny, C., & Reed, T. (2017). Civil society engagement in multi-stakeholder dialogue: A qualitative study exploring the opinions and perceptions of MeTA members. Journal of Pharmaceutical Policy and Practice, 10(1), 5. https://doi.org/10.1186/s40545-016-0096-0.CrossRefGoogle ScholarPubMed
Cameron, E., & Berger, J. (2005). Patents and public health: Principle, politics and paradox: British Academy Law Lecture. In Marshall, P. J. (Ed.), Proceedings of the British Academy, Volume 131, 2004 Lectures, pp. 331–369. British Academy. https://doi.org/10.5871/bacad/9780197263518.003.0012.Google Scholar
Carpiano, R. M., Callaghan, T., DiResta, R., et al. (2023). Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. Lancet (London, England), 401(10380), 967–970. https://doi.org/10.1016/S0140-6736(23)00136-8.CrossRefGoogle ScholarPubMed
Cassier, M. (2004). Brevets pharmaceutiques et santé publique en France: Opposition et dispositifs spécifiques d’appropriation des médicaments entre 1791 et 2004. Entreprises et histoire, 36(2), 29–47. https://doi.org/10.3917/eh.036.0029.CrossRefGoogle Scholar
Cassier, M. (2014). Patents and Health. In The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society. Wiley-Blackwell. https://doi.org/10.1002/9781118410868.wbehibs355.Google Scholar
Chabrol, F., David, P.-M., & Krikorian, G. (2017). Rationing hepatitis C treatment in the context of austerity policies in France and Cameroon: A transnational perspective on the pharmaceuticalization of healthcare systems. Social Science & Medicine, 187, 243–250. https://doi.org/10.1016/j.socscimed.2017.03.059.CrossRefGoogle ScholarPubMed
Chin, J. C., & Grossman, G. M. (1988). Intellectual property rights and north-south trade (Working Paper 2769). National Bureau of Economic Research. https://doi.org/10.3386/w2769.CrossRefGoogle Scholar
Christou, S. (2022a). Health movements (Europe). In Snow, D. A., della Porta, D., McAdam, D., & Klandermans, B. (Eds), The Wiley-Blackwell Encyclopedia of Social and Political Movements (pp. 1–7). John Wiley & Sons. https://doi.org/10.1002/9780470674871.wbespm569.Google Scholar
Christou, S. (2022b). The diffusion, modularisation and institutionalisation of direct social actions in healthcare. The Greek Healthcare Arena: 1983–2019. Scuola Normale Superiore.Google Scholar
Christou, S. (2024). Il diritto alla salute come master frame: Salute, sanità e cura nella pandemia. In della Porta, D., Chesta, R. E., Chironi, D., Felicetti, A., & Christou, S. (Eds.), Comunicare e partecipare durante una pandemia (pp. 139–166). Il Mulino.Google Scholar
Christou, S., & della Porta, D. (2024). Contesting patents on Covid-19 vaccines in the EU: the No Profit on Pandemic campaign.CrossRefGoogle Scholar
Collier, D., & Munck, G. L. (2017). Building blocks and methodological challenges: A framework for studying critical junctures (SSRN Scholarly Paper 3034920). https://papers.ssrn.com/abstract=3034920.Google Scholar
Corporate Europe Observatory. (2021a, May 7). The Commission’s pharma echo chamber. https://corporateeurope.org/en/2021/05/commissions-pharma-echo-chamber.Google Scholar
Corporate Europe Observatory. (2021b, June 4). Leaked documents show EU Council of ministers defined its position on TRIPS waiver for vaccines in secret. https://corporateeurope.org/en/2021/06/leaked-documents-show-eu-council-ministers-defined-its-position-trips-waiver-vaccines.Google Scholar
Correa, C. M. (2006). Implications of bilateral free trade agreements on access to medicines. Bulletin of the World Health Organization, 84(5), 399–404.CrossRefGoogle ScholarPubMed
Crespy, A., & Parks, L. (2017). The connection between parliamentary and extra-parliamentary opposition in the EU. From ACTA to the financial crisis. Journal of European Integration, 39, 1–15. https://doi.org/10.1080/07036337.2017.1309038.CrossRefGoogle Scholar
Cross, S., Rho, Y., Reddy, H., et al. (2021). Who funded the research behind the Oxford-AstraZeneca COVID-19 vaccine? Approximating the funding to the University of Oxford for the research and development of the ChAdOx vaccine technology (p. 2021.04.08.21255103). medRxiv. https://doi.org/10.1101/2021.04.08.21255103.CrossRefGoogle Scholar
Crossley, N. (2006). Contesting Psychiatry: Social Movements in Mental Health. Routledge.CrossRefGoogle Scholar
Cueto, M., Brown, T. M., & Fee, E. (2019). The World Health Organization: A History. Cambridge University Press. https://doi.org/10.1017/9781108692878.CrossRefGoogle Scholar
de Ruijter, A., Beetsma, R. M. W. J., Burgoon, B., Nicoli, F., & Vandenbroucke, F. (2020). EU Solidarity and Policy in Fighting Infectious Diseases: State of Play, Obstacles, Citizen Preferences and Ways Forward (SSRN Scholarly Paper No. 3570550). https://doi.org/10.2139/ssrn.3570550CrossRefGoogle Scholar
della Porta, D. (2020). Protests as critical junctures: Some reflections towards a momentous approach to social movements. Social Movement Studies, 19(5–6), 556–575. https://doi.org/10.1080/14742837.2018.1555458.CrossRefGoogle Scholar
della Porta, D. (2022). Contentious Politics in Emergency Critical Junctures: Progressive Social Movements during the Pandemic. Cambridge University Press. www.cambridge.org/core/elements/contentious-politics-in-emergency-critical-junctures/1D03059F92DF5DDA9338D17F174E6D29.CrossRefGoogle Scholar
della Porta, D. (2023). Regressive Movements in Times of Emergency: The Protests against Anti-Contagion Measures and Vaccination During the Covid-19 Pandemic. Oxford University Press. https://global.oup.com/academic/product/regressive-movements-in-times-of-emergency-9780198884309?cc=it&lang=en&.CrossRefGoogle Scholar
della Porta, D., Chesta, R. E., Chironi, D., Christou, S., & Felicetti, A. (2024). Comunicare e partecipare durante una pandemia. Il Mulino.Google Scholar
della Porta, D., Kriesi, H., & Rucht, D. (eds). (1999). Social Movements in a Globalizing World. Palgrave Macmillan.CrossRefGoogle Scholar
della Porta, D., & Lavizzari, A. (2022). Framing health and care: Legacies and innovation during the pandemic. Social Movement Studies, 23 (6), 738–755. https://doi.org/10.1080/14742837.2022.2134109.CrossRefGoogle Scholar
della Porta, D., & Parks, L. (2018). Social movements, the European crisis, and EU political opportunities. Comparative European Politics, 16, 85–102. https://doi.org/10.1057/s41295-016-0074-6.CrossRefGoogle Scholar
della Porta, D., Andretta, M., Mosca, L., & Reiter, H. (2006) Globalization from Below Transnational Activists and Protest Networks. University of Minnesota Press.Google Scholar
della Porta, D., Parks, L., & Portos, M. (2022). Environmentalism in Europe: Activism and advocacy. In Rayner, T., Szulecki, K., Jordan, A., & Oberthür, S. (Eds.), Handbook on European Union Climate Change Policy and Politics (pp. 98–112). Edward Elgar.Google Scholar
della Porta, D., & Tarrow, S., G. (eds.) 2005. Transnational Protest and Global Activism. Rowman & Littlefield.Google Scholar
DNDi. (2020, October 12). DNDi statement on India and South Africa request to WTO to waive IP rules for COVID-19 health tools. https://dndi.org/statements/2020/dndi-statement-india-south-africa-request-wto-waive-ip-rules-covid-19-health-tools/.Google Scholar
Drahos, P. (1995). Global Property Rights in Information: The story of TRIPS at the GATT. Prometheus, 13(1), 6–19. https://doi.org/10.1080/08109029508629187.CrossRefGoogle Scholar
Drahos, P. (2021). Public lies and public goods: Ten lessons from when patents and pandemics meet [Working Paper]. European University Institute. https://cadmus.eui.eu/handle/1814/71560.Google Scholar
Drugau-Constantin, A. L., & Anghel-Sienerth, A. K. (2022). Challenges of civic participation at EU level during Covid-19 pandemic: European citizens’ initiative. Applied Research in Administrative Sciences, 3(1), 4–10.CrossRefGoogle Scholar
Dyer, O. (2021). Covid-19: Countries are learning what others paid for vaccines. BMJ, 372, n281. https://doi.org/10.1136/bmj.n281.CrossRefGoogle ScholarPubMed
Engels, F. (2009). The Condition of the Working Class in England—Paperback—Friedrich Engels, David McLellan—Oxford University Press (D. McLellan, Ed.). Oxford University Press. https://global.oup.com/ukhe/product/the-condition-of-the-working-class-in-england-9780199555888.Google Scholar
Epstein, S. (1996). Impure Science: AIDS, Activism, and the Politics of Knowledge. University of California Press.Google ScholarPubMed
Epstein, S. (2007). Chapter 21: Patient groups and health movements. In Hackett, E. J., Amsterdamska, O., Lynch, M. E., & Wajcman, J. (Eds.), The Handbook of Science and Technology Studies (3rd ed., pp. 499–539). MIT Press.Google Scholar
Epstein, S. (2010). The strength of diverse ties *: Multiple hybridity in the politics of inclusion and difference in U.S. Biomedical research. In Social Movements and the Transformation of American Health Care. Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195388299.003.0006.Google Scholar
European Citizens’ Initiative. (n.d.). [Text]. Retrieved 2 May 2023, https://europa.eu/citizens-initiative/initiatives/details/2020/000005_en.Google Scholar
European Commission. (1998). European Commission (DG 1) note on the WHO’s Revised Drug Strategy. www.cptech.org/ip/health/who/eurds98.html.Google Scholar
European Commission (2009) Pharmaceutical Sector Inquiry: Final Report. Staff Working Paper Part 1. Directorate‑General for Competition. Available at: https://competition‑policy.ec.europa.eu/system/files/2022‑05/pharmaceutical_sector_inquiry_staff_working_paper_part1.pdf (accessed 3 September 2025).Google Scholar
European Commission. (2020). Von der Leyen [Text]. https://ec.europa.eu/commission/presscorner/detail/en/statement_20_741.Google Scholar
European Commission Competition Director-General. (2009). Pharmaceutical Sector Inquiry (pp. 1–533). European Commission.Google Scholar
Parliament, European. (2020, December 23). Parliamentary question- Answer for question E-005595/20. www.europarl.europa.eu/doceo/document/E-9-2020-005595-ASW_EN.html.Google Scholar
Parliament, European. (2023, March 31). European Citizens’ Initiative | Fact Sheets on the European Union. www.europarl.europa.eu/factsheets/en/sheet/149/european-citizens-initiative.Google Scholar
f_barca. (2021, February 3). Covid vaccine contracts: EU has hands tied, experts say. Https://Voxeurop.Eu/En/. https://voxeurop.eu/en/covid-vaccine-contracts-eu-has-hands-tied-experts-say/.Google Scholar
Ferraz, O. L. M. (2021). Health as a Human Right: The Politics and Judicialisation of Health in Brazil. Cambridge University Press. https://doi.org/10.1017/9781108678605.Google Scholar
Gabble, R., & Kohler, J. C. (2014). To patent or not to patent? The case of Novartis’ cancer drug Glivec in India. Globalization and Health, 10(1), 3. https://doi.org/10.1186/1744-8603-10-3.CrossRefGoogle ScholarPubMed
Gaffney, A., & Muntaner, C. (2018). Austerity and Healthcare. In Waitzkin, H. & The Working Group on Health Beyond Capitalism (Eds.), Health Care under the Knife- Moving beyond capitalism for our health (pp. 119–137). Monthly Review Express.Google Scholar
Galanti, C., & Christou, S. (forthcoming). Healthcare systems commodification between national and EU economic governance: Greece, Italy, and Romania between the economic and the Covid-19 crises. In Maccarrone, V. & Bieler, A. (Eds.), Critical Political Economy of the European Polycrisis. Edward Elgar.Google Scholar
Galanti, C., & Naughton, M. (2023). Using the unions: Healthcare struggles in Italy and Spain between trade unionism and self-organization. Partecipazione E Conflitto, 16(2), Article 2. https://doi.org/10.1285/i20356609v16i2p216.Google Scholar
Gamson, J. (1989). Silence, death and the invisible enemy: AIDS activism and social movement ‘newness’. Social Problems, 36(4), 351–367.CrossRefGoogle Scholar
Garattini, S. (2016). The European Medicines Agency is still too close to industry. BMJ, 353, i2412. https://doi.org/10.1136/bmj.i2412.CrossRefGoogle ScholarPubMed
Gaudillière, J. (2008). How pharmaceuticals became patentable: The production and appropriation of drugs in the twentieth century. History and Technology, 24(2), 99–106. https://doi.org/10.1080/07341510701810906.CrossRefGoogle Scholar
George, J., Sheshadri, R., & Grover, A. (2009). Intellectual property and Access to Medicines: Developments and civil society in India. In Reis, R., Veriano, T., & Cristina, M. (Eds.), Intellectual Property Rights and Access to ARV Medicines: Civil Society Resistance in the Global South (pp. 82–110). ABIA.Google Scholar
Gøtzsche, P. C. (2018). Patients not patents: Drug research and development as a public enterprise. European Journal of Clinical Investigation, 48(2), e12875. https://doi.org/10.1111/eci.12875.CrossRefGoogle Scholar
Graf, B. E. (1992). The politics of AIDS: An analysis of the AIDS Coalition to Unleash Power [University of Nevada]. https://digitalscholarship.unlv.edu/cgi/viewcontent.cgi?article=1204&context=rtds.Google Scholar
Greer, S. L., & Jarman, H. (2021). What is EU public health and why? Explaining the scope and organization of public health in the European Union. Journal of Health Politics, Policy and Law, 46(1), 23–47. https://doi.org/10.1215/03616878-8706591.CrossRefGoogle ScholarPubMed
Greer, S. L., de Ruijter, A., & Brooks, E. (2021). The COVID-19 pandemic: Failing forward in public health. In Riddervold, M., Trondal, J., & Newsome, A. (Eds.), The Palgrave Handbook of EU Crises (pp. 747–764). Springer International Publishing. https://doi.org/10.1007/978-3-030-51791-5_44.CrossRefGoogle Scholar
Guy, M. (2023). COVID-19: An accelerating force for EU activity in health? In Börner, S. & Seeleib-Kaiser, M. (Eds.), European Social Policy and the COVID-19 Pandemic: Challenges to National Welfare and EU Policy (pp. 246–271). Oxford University Press. https://doi.org/10.1093/oso/9780197676189.003.0010.CrossRefGoogle Scholar
Hamlin, C., & Jones, P. of E. H. C. (1998). Public Health and Social Justice in the Age of Chadwick: Britain, 1800–1854. Cambridge University Press.Google Scholar
Hassan, F., Yamey, G., & Abbasi, K. (2021). Profiteering from vaccine inequity: A crime against humanity? BMJ, 374, n2027. https://doi.org/10.1136/bmj.n2027.CrossRefGoogle ScholarPubMed
Heywood, M. (2001). Debunking ‘Conglomo-talk’: A case study of the amicus curiae as an instrument for advocacy, investigation and mobilisation. Law, Democracy & Development, 5(2), Article 2. https://doi.org/10.4314/ldd.v5i2.Google Scholar
Heywood, M. (2003). Preventing mother-to-child HIV transmission in South Africa: Background, strategies and outcomes of the treatment action campaign case against the minister of health. South African Journal on Human Rights, 19(2), 278–315. https://doi.org/10.1080/19962126.2003.11865183.Google Scholar
Heywood, M. (2009). South Africa’s treatment action campaign: Combining law and social mobilization to realize the right to health. Journal of Human Rights Practice, 1(1), 14–36. https://doi.org/10.1093/jhuman/hun006.CrossRefGoogle Scholar
Hopewell, K. (2015). Multilateral trade governance as social field: Global civil society and the WTO. Review of International Political Economy, 22(6), 1128–1158.CrossRefGoogle Scholar
IndustriALL Global Union. (2020, November 25). WTO members should ensure access to affordable medicines. IndustriALL. www.industriall-union.org/wto-members-should-ensure-access-to-affordable-medicines.Google Scholar
International Trade Union Confederation. (2021, March 1). Large expansion in vaccine production and equitable distribution are vital. www.ituc-csi.org/large-expansion-in-vaccine.Google Scholar
Iyengar, S., Tay-Teo, K., Vogler, S., et al. (2016). Prices, costs, and affordability of new medicines for Hepatitis C in 30 countries: An economic analysis. PLoS Medicine, 13(5), e1002032. https://doi.org/10.1371/journal.pmed.1002032.CrossRefGoogle ScholarPubMed
Jenkins, J. E. (2007). Baptism of fire: New Brunswick’s public health movement and the 1918 influenza epidemic. Canadian bulletin of medical history = Bulletin canadien d’histoire de la medecine, 24(2), 317–342. https://doi.org/10.3138/cbmh.24.2.317.Google ScholarPubMed
Kapczynski, A. (2009). Harmonization and its discontents. California Law Review, 97, 1571–1650.Google Scholar
Light, D. W., & Lexchin, J. (2021). The costs of coronavirus vaccines and their pricing. Journal of the Royal Society of Medicine, 114(11), 502–504. https://doi.org/10.1177/01410768211053006.CrossRefGoogle ScholarPubMed
Litsios, D. S. (2015). On the origin of primary health care. In Health For All: The Journey of Universal Health Coverage. Orient Blackswan. www.ncbi.nlm.nih.gov/books/NBK316278/.Google Scholar
Loff, B., & Heywood, M. (2002). Patents on drugs: Manufacturing scarcity or advancing health? The Journal of Law, Medicine & Ethics: A Journal of the American Society of Law, Medicine & Ethics, 30(4), 621–631. https://doi.org/10.1111/j.1748-720x.2002.tb00430.x.CrossRefGoogle ScholarPubMed
Lopert, R., & Gleeson, D. (2013). The high price of ‘free’ trade: U.S. trade agreements and access to medicines. The Journal of Law, Medicine & Ethics, 41(1), 199–223. https://doi.org/10.1111/jlme.12014.CrossRefGoogle Scholar
MacLeod, C. (1988). Inventing the Industrial Revolution: The English Patent System, 1660–1800. Cambridge University Press. https://doi.org/10.1017/CBO9780511522673.CrossRefGoogle Scholar
Mahler, H. (1981). The meaning of ‘health for all by the year 2000’. American Journal of Public Health, 106(1), 36–38. https://doi.org/10.2105/AJPH.2016.106136.Google Scholar
Malpani, R. (2007). All costs, no benefits: How TRIPS plus intellectual property rules in the US-Jordan FTA affect access to medicines (pp. 1–37) [Briefing Paper]. Oxfam International. https://policy-practice.oxfam.org/resources/all-costs-no-benefits-how-trips-plus-intellectual-property-rules-in-the-us-jord-114080/.Google Scholar
Maraboutaki, C. (2021). Gender and sexuality: The crime of rape in the Greek Penal Code. In Vaiou, D., Petraki, G., & Stratigaki, M. (Eds.), Gender Violence- Violence against Women (pp. 25–36). Alexandria. https://alexandria-publ.gr/shop/emfili-via-via-kata-ton-ginekon/.Google Scholar
McKee, M., & Ruijter, A. de. (2024). The path to a European Health Union. The Lancet Regional Health – Europe, 36, 1–6. https://doi.org/10.1016/j.lanepe.2023.100794.CrossRefGoogle ScholarPubMed
Médecins Sans Frontières Access Campaign. (1999, December 2). Major U.S. policy change opens door for poor countries to produce affordable drugs. https://amp.msfaccess.org/major-us-policy-change-opens-door-poor-countries-produce-affordable-drugs.Google Scholar
Médecins Sans Frontières Access Campaign. (2020a). India and South Africa proposal for WTO waiver from intellectual property protections for COVID-19-related medical technologies- Briefing Document.Google Scholar
Médecins Sans Frontières Access Campaign. (2020b, October 7). Civil society to WTO members: Support India and South Africa’s proposal for a waiver from IP protections for COVID-19 medical technologies | Médecins Sans Frontières Access Campaign. https://msfaccess.org/civil-society-wto-members-support-india-and-south-africas-proposal-waiver-ip-protections-covid-19.Google Scholar
Médecins Sans Frontières Access Campaign. (2020c, November 11). Governments must demand all coronavirus COVID-19 vaccine deals are made public. www.msf.org/governments-must-demand-all-coronavirus-covid-19-vaccine-deals-are-made-public.Google Scholar
Médecins Sans Frontières International. (2022, June 17). Lack of a real IP waiver on COVID-19 tools is a disappointing failure for people | MSF. Médecins Sans Frontières (MSF) International. www.msf.org/lack-real-ip-waiver-covid-19-tools-disappointing-failure-people.Google Scholar
Melucci, A. (1985). The symbolic challenge of contemporary movements. Social Research, 52(4), 789–816.Google Scholar
Mercer, M. A., Thompson, S. M., & de Araujo, R. M. (2014). The role of international NGOs in health systems strengthening: The case of Timor-Leste. International Journal of Health Services, 44(2), 323–335. https://doi.org/10.2190/HS.44.2.i.CrossRefGoogle ScholarPubMed
Mowery, D. C., & Sampat, B. N. (2001). University patents and patent policy debates in the USA, 1925–1980. Industrial and Corporate Change, 10(3), 781–814.CrossRefGoogle Scholar
Müller, H., Tömmel, I., Müller, H., & Tömmel, I. (Eds.). (2022). 311Strategic leadership: Ursula von der Leyen as President of the European Commission. In Women and Leadership in the European Union (pp. 311–330). Oxford University Press. https://doi.org/10.1093/oso/9780192896216.003.0017.CrossRefGoogle Scholar
Murphy-Gregory, H. (2012). Rethinking the roles of non-governmental organisations at the World Trade Organization. https://figshare.utas.edu.au/articles/journal_contribution/Rethinking_the_roles_of_non-governmental_organisations_at_the_World_Trade_Organization/22892297/1.CrossRefGoogle Scholar
Mylan, S., & Hardman, C. (2021). COVID-19, cults, and the anti-vax movement. The Lancet, 397(10280), 1181. https://doi.org/10.1016/S0140-6736(21)00443-8.CrossRefGoogle ScholarPubMed
Narayan, R., Schuftan, C., Donegan, B., Narayan, T., & R, R. B. (2020). The people’s health movement. In Oxford Research Encyclopedia of Global Public Health. https://doi.org/10.1093/acrefore/9780190632366.013.54.CrossRefGoogle Scholar
Natsis, Y. (2017, September 27). Reflection Paper | BENELUXA: First results of multi-country cooperation on medicine price negotiations – EPHA. Https://Epha.Org/. https://epha.org/discussion-paper-beneluxa/.Google Scholar
Nattrass, N. (2015). Millennium development goal 6: AIDS and the international health agenda. Journal of Human Development and Capabilities, Taylor & Francis Journals, 15(2-3), 232–246.Google Scholar
Noh, J.-E. (2024). The fight for global health justice: The advocacy of international humanitarian and development NGOs during the COVID-19 pandemic. VOLUNTAS: International Journal of Voluntary and Nonprofit Organizations. https://doi.org/10.1007/s11266-023-00630-7.CrossRefGoogle Scholar
Oxfam International. (2020, September 17). Small group of rich nations have bought up more than half the future supply of leading COVID-19 vaccine contenders. Oxfam International. www.oxfam.org/en/press-releases/small-group-rich-nations-have-bought-more-half-future-supply-leading-covid-19.Google Scholar
Oxfam International. (2022, June 17). WTO agrees a deal on patents for COVID vaccines—But campaigners say this is absolutely not the broad intellectual property waiver the world desperately needs. Oxfam International. www.oxfam.org/en/press-releases/wto-agrees-deal-patents-covid-vaccines-campaigners-say-absolutely-not-broad.Google Scholar
Peel, M., & Mancini, D. P. (2020, August 26). Covid-19 vaccine makers lobby EU for legal protection. Financial Times. https://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d.Google Scholar
Peigné, M. (2021, November 4). EU vaccine negotiators: Who are the secret names dealing with pharma? Investigate Europe. www.investigate-europe.eu/en/posts/function URL() {[native code]}/posts/eu-vaccine-negotiators-who-are-the-secret-names-dealing-with-pharma.Google Scholar
People’s Health Movement. (n.d.-a). Structure of PHM. Retrieved 2 August 2024, https://phmovement.org/structure-phm.Google Scholar
People’s Health Movement. (n.d.-b). The India South Africa waiver proposal: Documents and commentary. People’s Health Movement. Retrieved 28 April 2023, https://phmovement.org/the-india-south-africa-waiver-proposal/.Google Scholar
People’s Health Movement. (2014). E.6: Struggles for health in Europe. In Global Health Watch (Vol. 4). www.ghwatch.org/sites/www.ghwatch.org/files/E6_0.pdf.Google Scholar
People’s Health Movement, Oxfam International, Amnesty International, Health Action International, & etc. (2022, February 16). Civil Society Open Letter to the WTO Director General. www.twn.my/title2/health.info/2022/hi220204.htm.Google Scholar
People’s Medicines Alliance. (n.d.). Who we are. People’s Medicines. Retrieved 2 August 2024, https://peoplesmedicines.org/supporters/.Google Scholar
Pilling, D., Kuchler, H., & Mancini, D. P. (2021, November 30). The inside story of the Pfizer vaccine: ‘A once-in-an-epoch windfall’. Financial Times. www.ft.com/content/0cea5e3f-d4c4-4ee2-961a-3aa150f388ec.Google Scholar
Pope, R. J., & Flanigan, S. T. (2013). Revolution for breakfast: Intersections of activism, service, and violence in the black panther party’s community service programs. Social Justice Research, 26(4), 445–470. https://doi.org/10.1007/s11211-013-0197-8.CrossRefGoogle Scholar
Progressive International. (2020, October 15). Dear WTO: Covid-19 Vaccine is a Global Public Good. Progressive International. https://progressive.international/blueprint/b6cf1166-724d-46de-884e-058f771562ff-covid-19-response-group-to-wto-ensure-equitable-and-affordable-access-to-all-covid-19-health-technologies/en.Google Scholar
Roffe, P., & Spennemann, C. (2006). The impact of FTAs on public health policies and TRIPS flexibilities. International Journal of Intellectual Property Management, 1(1/2), 75–93. https://doi.org/10.1504/IJIPM.2006.011023.CrossRefGoogle Scholar
Rone, J. (2021). Contesting Austerity and Free Trade in the EU: Protest Diffusion in Complex Media and Political Arenas. Routledge. www.routledge.com/Contesting-Austerity-and-Free-Trade-in-the-EU-Protest-Diffusion-in-Complex-Media-and-Political-Arenas/Rone/p/book/9780367533465.Google Scholar
Safi, M. (2021, April 15). Oxford/AstraZeneca Covid vaccine research ‘was 97% publicly funded’. The Guardian. www.theguardian.com/science/2021/apr/15/oxfordastrazeneca-covid-vaccine-research-was-97-publicly-funded.Google Scholar
Satre, L. J. (1982). After the match girls’ strike: Bryant and May in the 1890s. Victorian Studies, 26(1), 7–31.Google Scholar
Sciacchitano, S., & Bartolazzi, A. (2021). Transparency in negotiation of European Union with big pharma on COVID-19 vaccines. Frontiers in Public Health, 9, 647955. https://doi.org/10.3389/fpubh.2021.647955.CrossRefGoogle ScholarPubMed
Sell, S. K. (2003). Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge University Press. https://doi.org/10.1017/CBO9780511491665.CrossRefGoogle Scholar
Sell, S. K. (2007). TRIPS-Plus free trade agreements and access to medicines. Liverpool Law Review, 28(1), 41–75. https://doi.org/10.1007/s10991-007-9011-8.CrossRefGoogle Scholar
Sellin, J. A. (2015). Does one size fit all? Patents, the right to health and access to medicines. Netherlands International Law Review, 62(3), 445–473. https://doi.org/10.1007/s40802-015-0047-5.CrossRefGoogle Scholar
Shadlen, K. C., Sampat, B. N., & Kapczynski, A. (2020). Patents, trade and medicines: Past, present and future. Review of International Political Economy, 27(1), 75–97. https://doi.org/10.1080/09692290.2019.1624295.CrossRefGoogle Scholar
Singer, M. (2009). Introduction to Syndemics: A Critical Systems Approach to Public and Community Health. John Wiley & Sons.Google Scholar
Smith, J., Pagnucco, R., & Romeril, W. (1994). Transnational social movement organisations in the global political arena. Voluntas: International Journal of Voluntary and Nonprofit Organizations, 5(2), 121–154. https://doi.org/10.1007/BF02353983.CrossRefGoogle Scholar
Smith, J., Chatfield, C., & Pagnucco, R. (eds). 1996. Solidarity beyond the State: The Dynamics of Transnational Social Movements. Syracuse University Press.Google Scholar
Son, K.-B., Lopert, R., Gleeson, D., & Lee, T.-J. (2018). Moderating the impact of patent linkage on access to medicines: Lessons from variations in South Korea, Australia, Canada, and the United States. Globalization and Health, 14(1), 101. https://doi.org/10.1186/s12992-018-0423-0.CrossRefGoogle ScholarPubMed
Stafford, N. (2017). Sofosbuvir faces fresh patent challenge in Europe. BMJ (Clinical Research Ed.), 356, j1632. https://doi.org/10.1136/bmj.j1632.CrossRefGoogle ScholarPubMed
Steffek, J. (2012). Awkward partners: NGOs and social movements at the WTO. In Daunton, M., Narlikar, A., & Stern, R. M. (Eds.), The Oxford Handbook on The World Trade Organization (pp. 301–319). Oxford University Press. https://doi.org/10.1093/oxfordhb/9780199586103.013.0015.Google Scholar
Stockdill, B. C. (2013). ACT UP (AIDS Coalition to Unleash Power). In Snow, D. A., Della Porta, D., Donatella, B. Klandermans, , & McAdam, D. (Eds.), The Wiley-Blackwell Encyclopedia of Social and Political Movements (p. wbespm223). Blackwell. https://doi.org/10.1002/9780470674871.wbespm223.Google Scholar
Swann, J. P. (1988). Academic Scientists and the Pharmaceutical Industry: Cooperative Research in Twentieth-Century America. Johns Hopkins University Press.Google Scholar
Szabó, I. G., Golden, D., & Erne, R. (2022). Why do some labour alliances succeed in politicizing Europe across borders? A comparison of the right2Water and fair transport European citizens’ initiatives. JCMS: Journal of Common Market Studies, 60(3), 634–652. https://doi.org/10.1111/jcms.13279.Google Scholar
t Hoen, E. (2002). TRIPS, pharmaceutical patents, and access to essential medicines: A long way from Seattle to Doha. Chicago Journal of International Law, 3(1), 27–46. https://doi.org/10.4324/9781315254227.Google ScholarPubMed
t Hoen, E., Berger, J., Calmy, A., & Moon, S. (2011). Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International AIDS Society, 14, 15. https://doi.org/10.1186/1758-2652-14-15.CrossRefGoogle Scholar
Tarrow, S. G., & McAdam, D. (2005). Scale shift in transnational contention. In della Porta, D. & Tarrow, S. G. (Eds.), Transnational Protest and Global Activism (pp. 121–149). Rowman & Littlefield.CrossRefGoogle Scholar
Taylor, V., & Zald, M. (2013). Health movements (United States). In Snow, D. A., Della Porta, D., Donatella, , Klandermans, B., & McAdam, D. (Eds.), The Wiley-Blackwell Encyclopedia of Social and Political Movements (p. wbespm306). Blackwell. https://doi.org/10.1002/9780470674871.wbespm306.Google Scholar
Taylor, V., & Zald, M. N. (2010). Conclusion: The shape of collective action in the U.S. health sector. In Social Movements and the Transformation of American Health Care. Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195388299.003.0018.Google Scholar
United Nations. (1948). Article 25, Universal Declaration of Human Rights. www.un.org/en/about-us/universal-declaration-of-human-rights.Google Scholar
Venizelos, G., & Trimithiotis, D. (2024). Analyzing pro-vax discourse during the pandemic: Techno scientism, elitism, anti-populism. The Communication Review. https://doi.org/10.1080/10714421.2024.2378576.CrossRefGoogle Scholar
Waitzkin, H. (1981). The social origins of illness: A neglected history. International Journal of Health Services: Planning, Administration, Evaluation, 11(1), 77–103. https://doi.org/10.2190/5CDV-P4FE-Y6HN-JACD.CrossRefGoogle Scholar
Webster, C. (2002). The National Health Service: A Political History. Oxford University Press.Google Scholar
Weisskircher, M. (2020). The European citizens’ initiative: Mobilization strategies and consequences. Political Studies, 68(3), 797–815. https://doi.org/10.1177/0032321719859792.CrossRefGoogle Scholar
WHO. (1948). Constitution of the World Health Organization. www.who.int/about/governance/constitution.Google Scholar
WHO Commission on Intellectual Property Rights, Innovation and Public Health. (2006). Public health, innovation and intellectual property rights. WHO. www.who.int/publications/i/item/9241563230.Google Scholar
Williams, M., & Ford, L. (1999). The World Trade Organisation, social movements and global environmental management. Environmental Politics, 8(1), 268–289. https://doi.org/10.1080/09644019908414447.CrossRefGoogle Scholar
Winslow, C.-E. A. (1943). The Conquest of Epidemic Disease: A Chapter in the History of Ideas. Princeton University Press.Google Scholar
World Trade Organisation. (2020, December 9). WTO receives petition asking for universally accessible and affordable COVID-19 vaccines. www.wto.org/english/news_e/news20_e/trip_09dec20_e.h.Google Scholar
Accessibility standard: WCAG 2.1 AA
Why this information is here
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.Accessibility Information
The PDF of this Element
complies with version 2.1 of the
Web Content Accessibility Guidelines
(WCAG), covering newer accessibility requirements and improved
user experiences and achieves the intermediate
(AA)
level of WCAG compliance, covering a wider range of accessibility requirements.
Content Navigation
Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Reading Order & Textual Equivalents
Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
Short alternative textual descriptions
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
Visual Accessibility
Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
Structural and Technical Features
ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.